from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3591c/-

LFCtreatmentdescriptionclass of inhibitor

-0.158

Amikacinug/mL Amikacintranslation

0.234

Cap5-10ug/mL Capreomycintranslation

-0.765

Rox10-50 ug/mL Roxithromycintranslation

-0.297

SM2-5 ug/mL Streptomycintranslation

1.369

Tet5-10 ug/mL Tetracyclinetranslation

1.555

Rif0.2-5ug/mL Rifampicintranscription

0.471

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.418

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.286

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.637

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.762

Clofazimine10-13 ug/mL Clofaziminerespiration

-1.100

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.744

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.494

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.105

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.340

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.099

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.317

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.196

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.096

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.176

KCN5-20 ug/mL Potassium cyaniderespiration

0.550

NaN30.2-2 mM Sodium aziderespiration

-0.135

Nigericin50 uM Nigericinrespiration

0.173

TRC10-150 ug/mL Triclosanrespiration

0.339

TRZ10-25 ug/mL Thioridazinerespiration

1.460

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.103

menadione6-10 ug/mL Menadionerespiration

-0.038

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.193

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.591

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.029

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.175

NRP_1Non-replicating persistence stage 1dosRassociated

-0.365

Amp0.2mg/mL AmpicillincellWall

0.242

Cephalexin20-100 ug/mL CephalexincellWall

-0.122

Cerulenin0.32-5 ug/mL CerulenincellWall

1.162

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.796

EMB10-20 ug/mL EthambutolcellWall

-0.462

Eta12-40 ug/mL EthionamidecellWall

-0.564

INH0.2-0.4 ug/mL IsoniazidcellWall

0.327

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.679

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.597

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.355

BZA0.12 mg/mL BenzamidearomaticAmides

0.097

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.085

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.735

H2O24 mM hydrogen peroxideDNAdamaging

-0.134

Levo10 ug/mL LevofloxacinDNAdamaging

-0.682

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.630

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.015

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.956

UVUV-irradiationDNAdamaging

0.304

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.193

Antimycin12.5-50 ug/mL Antimycin A?

0.172

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.022

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.033

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.076

PA8240.2-2 ug/mL PA-824?

0.415

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.179

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.106

Verapamil50 uM Verapamil?

-0.187

mercaptoethanol2 mM 2-Mercaptoethanol?

0.092

methoxatin10-20 ug/mL Methoxatin?